Figure 2
(A) Cumulative risk analysis for progression of study group patients ( n= 30) after allo-SCT; patients #3, #9, #10, #15, #21, #23, #24, and #28 were alive at last follow-up were censored. (B) Cumulative risk analysis for treatment-related mortality in the study group (n=30) after allo-SCT; patients #3, #9, #10, #15, #21, #23, #24, and #28 were alive at last follow-up were censored. Abbreviations: DOC, death of complications; allo-SCT, allogeneic stem cell transplantation.
